Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated with systemic chemotherapy
This study suggests that NLR may be a useful marker for predicting the initial treatment response to first-line chemotherapy and the prognosis for patients with advanced PDAC.
Authors
- Hidenao Noritake (ORCID: https://orcid.org/0000-0003-3649-5335)
- Kazuhito Kawata (ORCID: https://orcid.org/0000-0002-4986-8578)
- Makoto Takeda (ORCID: https://orcid.org/0000-0003-1523-1103)
- Ryo Kitajima
- Shingo Takatori (ORCID: https://orcid.org/0000-0002-5498-0564)
- Kensuke Kitsugi (ORCID: https://orcid.org/0009-0000-0683-2412)
- Satoru Furuhashi (ORCID: https://orcid.org/0000-0001-8732-3491)
- Takeshi Chida (ORCID: https://orcid.org/0000-0002-6389-0528)
- Shinya Ida
- Jun Ito (ORCID: https://orcid.org/0000-0002-8883-2623)
- Kazuyoshi Ohta (ORCID: https://orcid.org/0000-0002-4690-8706)
- Ryuta Muraki (ORCID: https://orcid.org/0000-0001-9261-3506)
- Yoshifumi Morita (ORCID: https://orcid.org/0000-0001-6940-2487)
- Tomohiko Hanaoka
- Akio Matsumoto
- Masahiro Umemura
- M. Yamashita (ORCID: https://orcid.org/0009-0008-6026-3378)
- Takafumi Suda (ORCID: https://orcid.org/0000-0001-5300-0504)
- Moe Matsumoto
Institutions
- Hamamatsu University School of Medicine (JP)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1080/07853890.2024.2398725
- Citations
- 7
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.98